Founder Intelligence

Geoffrey von Maltzahn PhD

Advancing technology at Generate Biomedicines requires rigorous software engineering, disciplined execution, and solving real operational bottlenecks for enterprise users.

Role
Co-Founder
Country
United States
Company founded
2018
Status
Active

Known for

Generate Biomedicines provides enterprise-grade artificial intelligence solutions, delivering specialized Generate Biomedicines Platform technology designed to optimize…

Ecosystem Connection Map

How this founder connects across companies, products, industries, and research on Brel.

Overview

Structured founder intelligence — role, focus, and why this person matters in the AI ecosystem.

Geoffrey von Maltzahn PhD serves as Co-Founder of Generate Biomedicines in United States, contributing to engineering leadership and technology commercialization.

Why it matters

Through their role at Generate Biomedicines, Geoffrey von Maltzahn PhD demonstrates how focused technical execution and product management drive sustainable growth in enterprise software.

Editorial insight

von Maltzahn co-founded Generate at Flagship Pioneering, helping launch a generative biology platform that has generated 42,000+ proteins and advanced AI-designed antibodies into clinical development.

Career & Timeline

Verified career context from this founder profile.

Career & Leadership

With extensive experience in technology organizations, Geoffrey von Maltzahn PhD emphasizes reliable software infrastructure and organizational execution at Generate Biomedicines.

Industry & Technical Contributions

At Generate Biomedicines, Geoffrey von Maltzahn PhD guides the technical roadmaps and product strategies that allow enterprise clients to automate workflows and optimize productivity.

  • Company founded 2018 · founded Generate Biomedicines was founded in 2018 per the company profile source on file. Source
  • 2018: Generate Biomedicines founded at Flagship Pioneering; Molly Gibson among co-founders. 2018 · development Source
  • January 2024: Generate expanded Amgen collaboration and reported first patient dosed in GB-0895 Phase 1. 2024 · development Source

Companies

Organizations connected to this founder in the Brel graph.

Products

Products and platforms linked to this founder or their organization.

  • Generate Platform Biotechnology

    Explore Generate Platform by Generate Biomedicines. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture...

    View product

Technologies & Expertise

Verified technology terms linked to this founder.

Industries & Use Cases

Sectors and use cases connected to this founder profile.

Ecosystem

Partnerships, acquisitions, and adjacency signals from the connected company graph.

Partnerships

  • January 2024: Generate expanded Amgen collaboration and reported first patient dosed in GB-0895 Phase 1.

Latest Developments

Recent milestones from the connected organization.

  • 2025–2026: GB-0895 advanced toward global Phase 3 studies for severe asthma; Mike Nally continues as CEO. Latest
  • Development 2018 · development Source
  • Leadership 2025 · leadership Source

Related Intelligence

Reports and insights editorially linked to this founder.

FAQ

Answers restated from verified fields on this profile.

Who is Geoffrey von Maltzahn PhD?

Geoffrey von Maltzahn PhD is a technology leader and entrepreneur currently serving as Co-Founder at Generate Biomedicines.

What company is Geoffrey von Maltzahn PhD associated with?

Geoffrey von Maltzahn PhD is associated with Generate Biomedicines, leading product and technical initiatives.

Where is Geoffrey von Maltzahn PhD based?

Geoffrey von Maltzahn PhD is based in United States.

What are Geoffrey von Maltzahn PhD's key contributions to the industry?

Geoffrey von Maltzahn PhD focuses on scalable software architecture, enterprise product development, and applied artificial intelligence leadership at Generate Biomedicines.

Sources & Verification

Verified
Last reviewed Aug 2026

Primary sources

In this profile